May 2017 FDA Recall Drug by Lantheus Mi Radipharmaceuticals Inc.
D-0942-2017 - Failed Impurities/Degradation Specifications; out of specification result for Acetonitrile residual solvent

This Class III drug recall was voluntarily initiated by Lantheus Mi Radipharmaceuticals Inc. on May 18, 2017 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications; out of specification result for acetonitrile residual solvent. The product was distributed in Puerto Rico and the recall is currently terminated.

Recall Number: D-0942-2017

Reason for Recall
Failed Impurities/Degradation Specifications; out of specification result for Acetonitrile residual solvent
Initiated
05-18-2017
Reported
07-12-2017
Quantity
26 doses

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Lantheus MI Radipharmaceuticals Inc.
Fludeoxyglucose F 18 Injection, 20mCi/mL to 200 mCi/mL at EOS, 30 mL Multiple-Dose Vial, Rx Only, Manufactured by: Lantheus MI Radiopharmaceuticals, Inc., San Juan, PR --- NDC 11994-015-01

Batch or Lot Expiration Information

Lot# Lot: FDG170518-01, exp 5/18/2017